Ronapreve

casirivimab and imdevimab · Roche Registration GmbH

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ronapreve, covering 2021-10-11 to 2026-01-23. Get the full timeline:

Most recent: EMA Withdrawn: Ronapreve (casirivimab;imdevimab) — Roche Registration GmbH